tiprankstipranks
Ziopharm Oncology (ZIOP)
NASDAQ:ZIOP
US Market

Ziopharm Oncology (ZIOP) Stock News & Sentiment

0 Followers
Understanding Changes in Ziopharm Oncology’s Risk Factors
PremiumMarket News
Understanding Changes in Ziopharm Oncology’s Risk Factors
3y ago
Ziopharm Oncology (ZIOP) is an American clinical-stage biopharmaceutical company focused on developing cancer therapies. The company is working on several product candidates at various stages of development. (See Insiders’ Hot ...Read more
Analysts: These 3 Penny Stocks May Very Well Be Worth the Risk
PremiumIdeas & Insights
Analysts: These 3 Penny Stocks May Very Well Be Worth the Risk
4y ago

News Score - Last 7 Days

Neutral
ZIOP
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ZIOP’s Media Buzz Sentiment?
4 articles about ZIOP were published this week. In an average week, 1.75 articles are published.
    What is ZIOP’s weekly average amount of articles?
    In an average week, 1.75 articles about ZIOP are published.
      What is ZIOP’s News Sentiment?
      50% of articles about ZIOP were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        CAPRCapricor Therapeutics
        0QBOColoplast A/S
        CUECue Biopharma
        TLPPFTelix Pharmaceuticals
        SRRASierra Oncology
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis